Literature DB >> 28149847

Does relief of outflow tract obstruction in patients with hypertrophic cardiomyopathy improve long-term survival? Implications for lowering the threshold for surgical myectomy and alcohol septal ablation.

Srihari S Naidu1, Julio A Panza1, David Spielvogel1, Ramin Malekan1, Joshua Goldberg1, Wilbert S Aronow1.   

Abstract

Entities:  

Year:  2016        PMID： 28149847      PMCID： PMC5233489          DOI： 10.21037/atm.2016.12.47

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  17 in total

1.  Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy.

Authors:  Shikhar Agarwal; E Murat Tuzcu; Milind Y Desai; Nicholas Smedira; Harry M Lever; Bruce W Lytle; Samir R Kapadia
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy.

Authors:  E Takagi; T Yamakado; T Nakano
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

3.  Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.

Authors:  Robbert C Steggerda; Kevin Damman; Jippe C Balt; Max Liebregts; Jurriën M ten Berg; Maarten P van den Berg
Journal:  JACC Cardiovasc Interv       Date:  2014-10-15       Impact factor: 11.195

4.  Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Davinder S Jassal; Tomas G Neilan; Michael A Fifer; Igor F Palacios; Patrica A Lowry; Gus J Vlahakes; Michael H Picard; Danita M Yoerger
Journal:  Eur Heart J       Date:  2006-06-14       Impact factor: 29.983

5.  Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.

Authors:  Robert A Leonardi; Evan P Kransdorf; David L Simel; Andrew Wang
Journal:  Circ Cardiovasc Interv       Date:  2010-03-02       Impact factor: 6.546

6.  Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.

Authors:  Sherif F Nagueh; Bertron M Groves; Leonard Schwartz; Karen M Smith; Andrew Wang; Richard G Bach; Christopher Nielsen; Ferdinand Leya; John M Buergler; Steven K Rowe; Anna Woo; Yolanda Munoz Maldonado; William H Spencer
Journal:  J Am Coll Cardiol       Date:  2011-11-22       Impact factor: 24.094

7.  Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Authors:  Paul Sorajja; Steve R Ommen; David R Holmes; Joseph A Dearani; Charanjit S Rihal; Bernard J Gersh; Ryan J Lennon; Rick A Nishimura
Journal:  Circulation       Date:  2012-10-17       Impact factor: 29.690

8.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

Review 9.  A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.

Authors:  Max Liebregts; Pieter A Vriesendorp; Bakhtawar K Mahmoodi; Arend F L Schinkel; Michelle Michels; Jurriën M ten Berg
Journal:  JACC Heart Fail       Date:  2015-10-07       Impact factor: 12.035

10.  Effects of surgical septal myectomy on left ventricular wall thickness and diastolic filling.

Authors:  Pedro F Monteiro; Steve R Ommen; Bernard J Gersh; Joseph A Dearani; Hartzell V Schaff; Rick A Nishimura; A Jamil Tajik
Journal:  Am J Cardiol       Date:  2007-10-24       Impact factor: 2.778
View more
  1 in total

1.  Surgical myectomy: Rationale and personalized technique.

Authors:  Hamood N Al Kindi; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.